Post-Operative Chemotherapy Regimens Prove Effective for Colon Cancer Patients

As Yasoda Dev, MD, medical oncologist and hematologist with the Cancer Center of Indiana pointed out, “Death rates from colorectal cancer have declined progressively since the mid-1990s in the United States. This improvement can be attributed to detection of the disease at an earlier stage and more effective treatments, particularly the post-operative use of advanced chemotherapy. Every patient’s treatment plan is different, but most include a six month long chemotherapy regimen using a cocktail of medications. Chemotherapy has also proven successful for inoperable colon cancers, raising median survival rates to more than three years, compared to approximately four months in untreated patients.”

“Post-operative use of chemotherapy after colon cancer resection has proven to be a highly effective treatment option. The risk of recurrence has been shown to drop by 30 percent, and death rates have declined by 32 percent in these patients. New treatments to avoid the bothersome side effects of chemotherapy have also become available, making this option a great scenario for a lot of patients.”

Yasoda Dev, MD
Board Certified Medical Oncologist and Hematologist
Cancer Center of Indiana